person · Reporting owner

READ IAN C

Disclosed activity across 6 companies

Tapewire entity: 15999
SEC CIK: 0001372915

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DXC Technology CoDXC · Entity 4594	Director	August 20, 2021	August 24, 2021
Empery Digital Inc.VLCN · Entity 21	Director	July 17, 2025	July 21, 2025
KIMBERLY CLARK CORPKMB · Entity 3103	Director	January 03, 2022	January 05, 2022
PFIZER INCPFE · Entity 2863	Director · Executive Chairman	March 04, 2019	March 06, 2019
Population Health Investment Co., Inc.PHIC · Entity 136038	Director · Executive Chairman	November 17, 2020	November 17, 2020
Viatris IncVTRS · Entity 3277	Director	March 21, 2022	March 23, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DXC Technology Co

Report date August 20, 2021 · Filed August 24, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	48,800	Reported balance After 2021-08-20 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2021-08-20 · Grant · Acquired 12,700 · Balance 48,800 F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2: Amount reported includes unvested RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2: Amount reported includes unvested RSUs.

Empery Digital Inc.

Report date July 17, 2025 · Filed July 21, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	30,000	Reported balance After 2025-07-21 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2025-07-21 · Grant · Acquired 30,000 · Balance 30,000 F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2035-07-17	Direct	298,802	Reported balance After 2025-07-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-07-17 · Grant · Acquired 298,802 · Balance 298,802 F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025.

F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan.

KIMBERLY CLARK CORP

Report date January 03, 2022 · Filed January 05, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Share UnitsSEC Table II · derivative / convertible security	Direct	37,206	Reported balance After 2022-01-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-01-03 · Grant · Acquired 1,299 · Balance 37,206 F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

PFIZER INC

Report date March 04, 2019 · Filed March 06, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,109,202	Ending reported balance After 2019-03-04 transaction · row 26 26 source rows · reconciled sequence Row 1 · 2019-03-04 · Sale · Disposed 3,722 · Balance 1,635,558 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 2 · 2019-03-04 · Sale · Disposed 4,258 · Balance 1,631,300 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 3 · 2019-03-04 · Sale · Disposed 4,392 · Balance 1,626,908 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 4 · 2019-03-04 · Sale · Disposed 4,489 · Balance 1,622,419 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 5 · 2019-03-04 · Sale · Disposed 5,812 · Balance 1,616,607 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 6 · 2019-03-04 · Sale · Disposed 6,284 · Balance 1,610,323 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 7 · 2019-03-04 · Sale · Disposed 6,960 · Balance 1,603,363 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 8 · 2019-03-04 · Sale · Disposed 7,584 · Balance 1,595,779 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 9 · 2019-03-04 · Sale · Disposed 8,427 · Balance 1,587,352 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 10 · 2019-03-04 · Sale · Disposed 10,725 · Balance 1,576,627 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 11 · 2019-03-04 · Sale · Disposed 11,804 · Balance 1,564,823 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 12 · 2019-03-04 · Sale · Disposed 11,908 · Balance 1,552,915 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 13 · 2019-03-04 · Sale · Disposed 12,457 · Balance 1,540,458 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 14 · 2019-03-04 · Sale · Disposed 12,623 · Balance 1,527,835 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 15 · 2019-03-04 · Sale · Disposed 12,787 · Balance 1,515,048 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 16 · 2019-03-04 · Sale · Disposed 12,971 · Balance 1,502,077 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 17 · 2019-03-04 · Sale · Disposed 13,275 · Balance 1,488,802 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 18 · 2019-03-04 · Sale · Disposed 14,739 · Balance 1,474,063 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 19 · 2019-03-04 · Sale · Disposed 16,537 · Balance 1,457,526 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 20 · 2019-03-04 · Sale · Disposed 21,624 · Balance 1,435,902 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 21 · 2019-03-04 · Sale · Disposed 28,599 · Balance 1,407,303 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 22 · 2019-03-04 · Sale · Disposed 34,216 · Balance 1,373,087 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 23 · 2019-03-04 · Sale · Disposed 52,878 · Balance 1,320,209 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 24 · 2019-03-04 · Sale · Disposed 69,362 · Balance 1,250,847 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 25 · 2019-03-04 · Sale · Disposed 69,433 · Balance 1,181,414 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 26 · 2019-03-04 · Sale · Disposed 72,212 · Balance 1,109,202 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018.
Common StockSEC Table I · non-derivative	IndirectBy Rule 16b-3 Plan	11,442	Reported balance Holding disclosure · report date 2019-03-04 · row 27 Holding and transaction disclosures are not merged. 1 source row Row 27 · Balance 11,442

Filing footnotes · ownership attribution and instrument terms

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018.

Population Health Investment Co., Inc.

Report date November 17, 2020 · Filed November 17, 2020

This filing explicitly reported no securities owned.

Viatris Inc

Report date March 21, 2022 · Filed March 23, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,497	Reported balance After 2022-03-21 transaction · row 1 1 source row Row 1 · 2022-03-21 · Exercise / conversion · Acquired 166 · Balance 14,497 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security	Direct	165.5224	Reported balance After 2022-03-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-03-21 · Grant · Acquired 165.5224 · Balance 165.5224 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-03-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-03-21 · Exercise / conversion · Disposed 165.5224 · Balance 0 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Filing footnotes · ownership attribution and instrument terms

F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 04, 2017 Filed Aug 8, 2017 21:02 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	68,834	$34.00	$2,340,356.00	Disclosure SEC source: 0001225208-17-013378 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 221,955 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2017. F2 · balance_after: In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 119,973 shares were transferred from the GRAT to the reporting person's direct ownership on March 16, 2017. Read SEC document
August 04, 2017 Filed Aug 8, 2017 21:02 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	28,116	$34.00	$955,944.00	Disclosure SEC source: 0001225208-17-013378 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,293 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2017. F2 · balance_after: In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 119,973 shares were transferred from the GRAT to the reporting person's direct ownership on March 16, 2017. Read SEC document
July 05, 2017 Filed Jul 7, 2017 16:00 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	187.6376	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-17-012428 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,075.7109 Underlying: Common Stock · 187.6376 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
April 04, 2017 Filed Apr 7, 2017 01:19 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	181.2556	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-17-007770 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888.0733 Underlying: Common Stock · 181.2556 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
February 27, 2017 Filed Mar 1, 2017 22:10 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	55,609	$34.28	$1,906,276.52	Disclosure SEC source: 0001225208-17-005110 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,531 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 27, 2017 Filed Mar 1, 2017 22:10 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	53,609	$34.28	$1,837,716.52	Disclosure SEC source: 0001225208-17-005110 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,140 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document
February 27, 2017 Filed Mar 1, 2017 22:10 UTC	PFIZER INC PFE · Entity 2863	GrantCommon Stock	110,011	$0.00	$0.00	Disclosure SEC source: 0001225208-17-005110 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,749 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	438,005	$0.00 Strike: $34.06	$0.00	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,005 Underlying: Common Stock · 438,005 shares Expires 2024-02-23 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	527,597	$0.00 Strike: $34.06	$0.00	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · derivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,597 Underlying: Common Stock · 527,597 shares Expires 2022-02-23 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionStock Appreciation Rights · Derivative	788,835	$0.00 Strike: $21.03	$0.00	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · derivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 788,835 shares Expires 2017-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	381,914	$32.49	$12,408,385.86	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,738 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	201,441	$34.06	$6,861,080.46	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 922,652 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document
February 23, 2017 Filed Feb 27, 2017 23:55 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	788,835	$21.03	$16,589,200.05	Disclosure SEC source: 0001225208-17-004783 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	181.9462	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-17-000790 · doc4.xml · derivative · entry 2 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,706.8177 Underlying: Common Stock · 181.9462 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
January 03, 2017 Filed Jan 5, 2017 22:50 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,746	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-17-000790 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,524.8715 Underlying: Common Stock · 1,746 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
October 04, 2016 Filed Oct 6, 2016 20:20 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	169.0727	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-16-040246 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,778.8715 Underlying: Common Stock · 169.0727 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
August 03, 2016 Filed Aug 5, 2016 21:29 UTC	PFIZER INC PFE · Entity 2863	OtherCommon Stock	954,993	$35.29	$33,701,702.97	Disclosure SEC source: 0001225208-16-037551 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,093 F1 · shares: The reporting person transferred shares held in the Pfizer Inc Deferred Compensation Plan ("DCP") into an alternative investment under the DCP in accordance with the DCP's investment alternatives pursuant to the Diversification and Sales Plan entered into on June 2, 2016 between the reporting person and the issuer, which plan was intended to comply with SEC Rule 10b5-1. Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	25,000	$0.00 Strike: $24.43	$0.00	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	250,000	$0.00 Strike: $25.87	$0.00	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · derivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2017-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	271,092	$33.80	$9,162,909.60	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,196,738 Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	3,908	$33.81	$132,129.48	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,467,830 Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	25,000	$24.43	$610,750.00	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 09, 2016 Filed May 11, 2016 22:03 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	250,000	$25.87	$6,467,500.00	Disclosure SEC source: 0001225208-16-033171 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 29, 2016 Filed Mar 2, 2016 22:08 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	94	$29.67	$2,788.98	Disclosure SEC source: 0001225208-16-028964 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,631 Underlying: Common Stock · 94 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
February 28, 2016 Filed Mar 2, 2016 00:32 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	30,702	$30.23	$928,121.46	Disclosure SEC source: 0001225208-16-028816 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,375 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 28, 2016 Filed Mar 2, 2016 00:32 UTC	PFIZER INC PFE · Entity 2863	GrantCommon Stock	60,737	$0.00	$0.00	Disclosure SEC source: 0001225208-16-028816 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,664,077 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 25, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	500,770	$0.00 Strike: $30.59	$0.00	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,770 Underlying: Common Stock · 500,770 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document
February 25, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	560,345	$0.00 Strike: $30.59	$0.00	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · derivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,345 Underlying: Common Stock · 560,345 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionStock Appreciation Rights · Derivative	584,112	$0.00 Strike: $18.90	$0.00	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · derivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 584,112 shares Expires 2016-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	275,619	$29.67	$8,177,615.73	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,603,340 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	151,192	$30.02	$4,538,783.84	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,878,959 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:05 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	584,112	$18.90	$11,039,716.80	Disclosure SEC source: 0001225208-16-028385 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document
January 13, 2016 Filed Jan 15, 2016 00:43 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	693	$30.37	$21,046.41	Disclosure SEC source: 0001225208-16-024117 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,514 Underlying: Common Stock · 693 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
December 31, 2015 Filed Jan 4, 2016 17:49 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	145	$32.28	$4,680.60	Disclosure SEC source: 0001225208-16-023054 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,749 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
December 15, 2015 Filed Dec 16, 2015 23:55 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	145	$32.26	$4,677.70	Disclosure SEC source: 0001225208-15-022516 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,609 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
November 30, 2015 Filed Dec 2, 2015 17:15 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	143	$32.77	$4,686.11	Disclosure SEC source: 0001225208-15-021593 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,486 Underlying: Common Stock · 143 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
November 13, 2015 Filed Nov 16, 2015 22:48 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	141	$33.27	$4,691.07	Disclosure SEC source: 0001225208-15-020945 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,284 Underlying: Common Stock · 141 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
October 30, 2015 Filed Nov 2, 2015 21:19 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	138	$33.82	$4,667.16	Disclosure SEC source: 0001225208-15-020177 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,495 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
October 15, 2015 Filed Oct 16, 2015 22:39 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	137	$34.08	$4,668.96	Disclosure SEC source: 0001225208-15-019678 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,328 Underlying: Common Stock · 137 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
October 12, 2015 Filed Oct 14, 2015 20:09 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	633	$33.22	$21,028.26	Disclosure SEC source: 0001225208-15-019537 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,224 Underlying: Common Stock · 633 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
September 30, 2015 Filed Oct 1, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	149	$31.41	$4,680.09	Disclosure SEC source: 0001225208-15-018894 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,644 Underlying: Common Stock · 149 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
September 15, 2015 Filed Sep 17, 2015 00:39 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	141	$33.17	$4,676.97	Disclosure SEC source: 0001225208-15-018462 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,436 Underlying: Common Stock · 141 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
August 31, 2015 Filed Sep 1, 2015 22:41 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	145	$32.22	$4,671.90	Disclosure SEC source: 0001225208-15-017796 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,305 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
August 14, 2015 Filed Aug 18, 2015 12:03 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	132	$35.32	$4,662.24	Disclosure SEC source: 0001225208-15-017135 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,902 Underlying: Common Stock · 132 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
July 31, 2015 Filed Aug 4, 2015 21:43 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	130	$36.06	$4,687.80	Disclosure SEC source: 0001225208-15-016427 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,234 Underlying: Common Stock · 130 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
July 15, 2015 Filed Jul 17, 2015 13:27 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	134	$34.98	$4,687.32	Disclosure SEC source: 0001225208-15-015575 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,130 Underlying: Common Stock · 134 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
July 13, 2015 Filed Jul 14, 2015 22:54 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	604	$34.82	$21,031.28	Disclosure SEC source: 0001225208-15-015458 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,002 Underlying: Common Stock · 604 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
June 30, 2015 Filed Jul 2, 2015 18:09 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	139	$33.53	$4,660.67	Disclosure SEC source: 0001225208-15-014906 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,428 Underlying: Common Stock · 139 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
June 15, 2015 Filed Jun 16, 2015 20:21 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	137	$34.04	$4,663.48	Disclosure SEC source: 0001225208-15-013981 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,271 Underlying: Common Stock · 137 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
May 29, 2015 Filed Jun 1, 2015 22:16 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	135	$34.75	$4,691.25	Disclosure SEC source: 0001225208-15-013089 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,108 Underlying: Common Stock · 135 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.